(NASDAQ: FLGT) Fulgent Genetics's forecast annual revenue growth rate of 8.05% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 4.78%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.61%.
Fulgent Genetics's revenue in 2025 is $303,223,000.On average, 2 Wall Street analysts forecast FLGT's revenue for 2025 to be $9,789,996,633, with the lowest FLGT revenue forecast at $9,745,919,610, and the highest FLGT revenue forecast at $9,834,073,656. On average, 2 Wall Street analysts forecast FLGT's revenue for 2026 to be $10,826,724,953, with the lowest FLGT revenue forecast at $10,731,530,826, and the highest FLGT revenue forecast at $10,921,919,080.
In 2027, FLGT is forecast to generate $11,892,072,730 in revenue, with the lowest revenue forecast at $11,818,151,888 and the highest revenue forecast at $11,965,993,571.